Novasep has finalized the set-up of its new synthesis lab and kilo lab at its U.S. facility in Boothwyn, PA, beginning production of kilogram scale batches of synthetic molecules for biological testing and preclinical trials.
 
The facility is equipped with jacketed reactors ranging from 100mL to 50L in size and with a 35L filter dryer for isolation of kilogram quantities of compound. The expansion includes all the necessary equipment for standard and cryogenic chemistry. Purification services include the complete portfolio of Novasep preparative chromatography technologies, such as HPLC (Hipersep) and SFC (Supersep), with all the required analytical tools for process R&D.
 
“Drug developers in the U.S. are responding positively to our extended CMO services that support their early stage programs,” said Andrew Brennan, general manager at Novasep’s US operations. “The opening day was held together with our customers and Novasep’s scientific board member Prof Alois Fürstner, who made an inspiring presentation on catalysis. This was a great way to kick-off the opening of our new lab.”